Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer

BACKGROUND: Breast cancer (BC) is a disease with variable morphology, clinical behaviour and response to therapy. Identifying factors associated with the progression of early-stage BC can help understand the risk of metastasis and guide treatment decisions. Myxovirus resistance 1 (MX1), which is inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljohani, Abrar I., Joseph, Chitra, Kurozumi, Sasagu, Mohammed, Omar J., Miligy, Islam M., Green, Andrew R., Rakha, Emad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220876/
https://www.ncbi.nlm.nih.gov/pubmed/32350677
http://dx.doi.org/10.1007/s10549-020-05646-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220876/
https://www.ncbi.nlm.nih.gov/pubmed/32350677
http://dx.doi.org/10.1007/s10549-020-05646-x

Ejemplares similares